Since its founding in 2000, WuXi AppTec’s mission has remained constant: to help global customers and partners discover, develop, and manufacture pharmaceuticals and healthcare products to benefit patients in need.

Over the past 25 years, WuXi AppTec has partnered with thousands of customers worldwide, from the global top pharmaceutical companies to startups, biotechs, and research institutions. These collaborations are grounded in scientific expertise, operational excellence, and trust among private sector organizations, and put patients at the center of everything. The company’s reputation has been built project by project through the delivery of high-quality research, development, and manufacturing services that help partners advance promising medicines toward commercialization.

How Does WuXi AppTec Support Every Stage of Drug Development While Ensuring Transparency?

WuXi AppTec operates as a Contract Research, Development, and Manufacturing Organization (CRDMO), providing integrated services that support partners across the drug development process. Under this model, WuXi AppTec acts as a scientific service provider, while customers retain full ownership of their intellectual property, research programs, and resulting medicines. Its operations are exclusively focused on supporting commercial healthcare innovation and serving the global pharmaceutical and life sciences industry.

This business model is fundamentally built on transparency, regulatory oversight, and trust from our global partners. WuXi AppTec facilities are regularly audited by multinational pharmaceutical companies and inspected by regulatory authorities to ensure compliance with stringent global quality standards. The company’s value proposition depends on maintaining an open and highly regulated operating environment that meets the expectations of international customers and regulators—reflected in its transparent and globally diverse customer base.

How Does WuXi AppTec Empower Cross-border Innovation under Its Unwavering Vision and Mission?

“Every drug can be made, and every disease can be treated” has been WuXi AppTec’s vision, and there is little doubt that this aspiration is shared by researchers and innovators around the world, regardless of nationality, ethnicity, or background. At its heart is a simple belief: scientific innovation has no borders. 

Guided by this global vision, WuXi AppTec was founded with a clear mission—to enable the discovery and development of new therapies for patients. Over the past two decades, the company has worked with partners across North America, Europe, Asia, and other regions, ranging from leading global pharmaceutical companies to emerging biotech startups. This global vision is supported by WuXi AppTec’s extensive network and collaborative efforts.

WuXi AppTec has built a global enabling network spanning more than 20 facilities across the U.S., Europe, and Asia, supporting innovation that serves patients worldwide. This international footprint—shaped by a diverse customer base and sustained cross-border scientific collaboration—underscores its longstanding role as a global enabler in the healthcare ecosystem.

In the U.S. in particular, this commitment is reflected in steady, long-term investment. The company has been operating in four states, creating high-quality jobs and strengthening local innovation capacity. With its Middletown, Delaware site set to begin operations by the end of 2026, WuXi AppTec continues to deepen its presence—translating global capability into local impact, and local investment into global outcomes.

This patient-centered mission has also shaped the company’s investments, partnerships, and operations from the beginning. It underscores a clear reality: WuXi AppTec operates to support global medical innovation and healthcare advancement, and exists with the sole objective of helping bring new treatments to patients. 

For more than 25 years, WuXi AppTec has thrived on openness, collaboration, and rigorous oversight—working with innovators across North America, Europe, Asia, and beyond. Every lab, every project, and every investment is focused on advancing medical discoveries and bringing life-saving and life-improving therapies to those who need them.